Skip to main content
Article
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
(2017)
  • Philip J. Mease, University of Rochester Medical Center
  • Arthur Kavanaugh, University of Washington
  • Andreas Reimold, University of Texas Southwestern Medical Center
  • Hasan Tahir, Barts Health NHS Trust
  • Juergen Rech
  • Stephen Hall, Monash University
  • Piet P.M.M. Geusens, University Medical Center
  • Pellet Pascale
  • Evie Marie Delicha
  • Luminata Pricop
  • Shepard Mpofu
Publication Date
January 1, 2017
Citation Information
Philip J. Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, et al.. "Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial" (2017)
Available at: http://works.bepress.com/philip-mease/71/